期刊
JOURNAL OF HYPERTENSION
卷 19, 期 1, 页码 1-11出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00004872-200101000-00001
关键词
pharmacology; genetics; hypertension; blood pressure
资金
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053330] Funding Source: NIH RePORTER
- NHLBI NIH HHS [R01-HL53330] Funding Source: Medline
Pharmacogenetic investigation seeks to identify genetic factors that contribute to interpatient and interdrug variation in responses to antihypertensive drug therapy. Classical studies have characterized single gene polymorphisms of drug metabolizing enzymes that are responsible for large interindividual differences in pharmacokinetic responses to several antihypertensive drugs. Progress is being made using candidate gene and genome scanning approaches to identify and characterize many additional genes influencing pharmacodynamic mechanisms that contribute to interindividual differences in responses to antihypertensive drug therapy. Knowledge of polymorphic variation in these genes will help to predict individual patients' blood pressure responses to antihypertensive drug therapy and may also provide new insights into molecular mechanisms responsible elevation of blood pressure. (C) 2001 Lippincott Williams & Wilkins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据